Intracellular staining was performed with the Foxp3 staining buffer kit, according to the manufacturer’s protocol (eBioscience or BD Biosciences). CD4 microbeads were purchased from Miltenyi Biotec (Auburn, CA). Flow cytometry analysis was performed using FlowJo software. Peripheral LNs and spleens were harvested from 8-week-old female mice. CD4+ T cells where enriched by Automacs using CD4 microbeads, labeled with anti-CD4 PE-Cy5, anti-CD25 PE, and CD45RB FITC or anti-CD4 selleck kinase inhibitor PE-Cy5 and anti-CD45RB PE and purified by cell sorting. The purity of CD4+CD25−CD45RBhi, CD4+CD25+, CD4+GFP−CD45RBhi, CD4+GFP+ cells was >98%. RAG KO mice

were injected i.v. with sorted CD4+ T-cell subpopulations in PBS. Mice received 5 × 105 CD4+CD45RBhigh from WT GITR or GITR KO mice alone or in combination with 2 × 105 CD4+ GFP+ GITR WT, CD4+ CD25+ GITR WT, or CD4+ CD25+ GITR KO cells; one group of mice received 2 × 105 CD4+ GFP+ GITR WT alone. Fc-GITR-L (200 μg) was injected i.v. one day after T-cell reconstitution, and then once weekly until the study was terminated. Mice were weighed weekly basis. CD4+CD25−T cells and CD4+CD25+ T cells were purified by cell sorting; postsort purity was >98%. Suppression assays were performed as previously described [3]. Statistical studies were compared using Mann–Whitney U test, and differences were considered statistically significant with p < 0.05. These studies Ivacaftor price were supported by funds

from the Intramural Program of the National Institute of Allergy and Infectious Diseases. The authors declare no Unoprostone financial or commercial conflict of interest. As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors. Figure S1. Fc-GITR-L expands the absolute numbers of Treg and Tconv cells, has no effect on their suppressive function in vitro. C57BL/6J mice were injected with human IgG1 (solid circle)

or Fc-GITR-L i.p. (open circle). Sixty-four hours after treatment, mice were injected with BrdU and 8 hours later total LN and spleen where harvested and BrdU incorporation determined by flow cytometry. (A) Percentage of Foxp3+ and Foxp3- T cells that incorporated BrdU. Data are derived from 4 mice per group. (B) Cell sorted CD4+CD25+ T cells from IgG1 or Fc-GITR-L injected mice were cultured at the indicated ratio with CD4+CD25- T cells and the mixture was activated with anti-CD3 monoclonal antibody and irradiated APC. (C) C57BL/6J mice were injected with human IgG1 (solid circle) or Fc-GITR-L i.p. (open circle), mice where harvested on day 3, 6 and 9 post Fc-GITR-L treatment. (∗∗∗, P <0.0001). The data represents the mean ± SEM, derived from four mice per group and representative of 3 independent experiments. Figure S2.